The hyper-constrained nucleoside, methylene-bridged hexopyranosyl nucleoside (BHNA) was incorporated into the antisnese oligonucleotides (AON), which show more preference for binding toward the complementary RNA (T m loss by ca 5°C) than that with the complementary DNA (T m loss by 10°C), vis-à-vis corresponding native duplex. The origin of reduction of T m of the duplexes formed by the BHNA incorporated AON and the complementary RNA or DNA was further investigated by thermal denaturation study with the single-mismatched DNA or RNA, CD spectroscopy, RNase H digestion study, as well as by molecular model building. These studies showed that the introduction of BHNA causes only a limited local conformational perturbation in the AON/RNA heteroduplex, whereas it affects the global conformation in the AON-DNA duplex. BHNA incorporated AONs also show improved stability in the human blood serum, which may prove to have some potential therapeutic application.
Introduction
Conformationally-constrained oligonucleotides have attracted considerable interest in the last two decades because they enable us to dictate specific conformational character in to the therapeutically interesting oligonucleotides, thereby allowing to steer their biological properties, as required in the antisense, siRNA or triplex strategy. [1] [2] [3] The pentose-sugar moiety in natural nucleos(t)ide is very flexible compared to those of the hexose-based oligos, and consequently can adopt a dynamic equilibrium of several sugar pseudorotamers. 4, 5 It has been however found that the North-type (34º > P> -1º, Φ m > 30º) or South-type (194º > P > 137º, Φ m > 48º)
) or the carbocylic chain (carba-LNA 13 and carba-ENA 13, 14 ) , or by a covalent linkage between C1′ and C2′ (such as oxetane 15 or azetidine 16, 17 types of constraints) result in to a conformationally-constrained North-type sugar. Oligonucleotides with these types of covalently constrained nucleosides can also potentially preorganize the single-stranded oligonucleotide in to a helical form, which, in turn, show much improved affinity toward complementary RNA (3-8ºC/modification, with the exception of C1′ and C2′ constrained systems) as well as to DNA 18 ;
they also show improved resistance toward enzyme degradation. 13, 17 ( 3) The AONs produced by the replacement of the pentofuranosyl sugar with the hexopyranosyl sugar 19 give thermodynamically stable duplexes with the target DNA or RNA. It is because, first, the sixmembered ring system adopt a rigid chair conformation, requiring a less negative entropy change during the duplex formation; and second, the interstrand phosphate distance in the six-membered pyranosyl-modified system is larger than in the natural nucleic acid duplexes giving a relatively less interstrand charge repulsion compared to the native counterpart. 19 Many different types of pyranosyl modified nucleosides have been so far incorporated in to AONs, and their affinity toward complementary RNA or DNA, as well as the biochemical features have been studied by the groups of Herdewijn and Eschenmoser: 2 AONs composed of homo-DNA ( Figure 1 ) is almost linear, and not able to form duplexes with either RNA or DNA 19, 20 , While HNA 21, 22 , CNA 23 and CeNA [24] [25] [26] all have improved affinity toward RNA and show improved nuclease resistance compared to the native counterpart. Amongst these the CeNA modified AONs have attracted more attention because they are able to activate RNase H, resulting in cleavage of the RNA strand in the AON-RNA heteroduplexes. 28 (BHNA, Scheme 1), which is a member of pyranose sugar family but is more rigid than any other reported constrained nucleoside. Here, we report the incorpoation of this hyper-constrained BHNA nucleoside into AON by the phosphoramidite-based DNA synthesis. We also report their affinity and specificity toward the complementary RNA and DNA, studied by UV melting experiment.
We have also measured the CD spectra of their homo and heteroduplexes to evidence their global structure, which was also confirmed by RNase H foot printing experiment. It has also turned out that modification of the AON with the new hyper-modified pyranose-modified molecules, as in 1, greatly improve human blood serum stability in comparison with the native counterpart.
Results (A) Phosphoramidite synthesis
During our effort to functionalize the carbocyclic moiety of the 5-membered carba-LNA 13 through new synthetic routes 27 , we attempted to remove the 6′-hydroxyl group of 6′-hydroxy-6′-methyl-carba-LNA 27 , prepared from 6′-hydroxy-carba-LNA 27, 28 Unexpectedly, a unique stereospecifically rearranged compound 1 (Scheme 1) was obtained 28 during the radical deoxygenation of 6′-methyloxalyl-6′-methyl-carba-LNA in addition to a diastereomeric mixture of C6′-reduced products. 27, 28 It turned out that this radical rearrangement only takes place when the tertiary radical is formed from the 5-membered conformationallyconstrained 6′-methyloxalyl-6′-methyl-carba-LNA 27 . The synthetic implication and mechanistic studies of this unusual rearrangement will be published elsewhere. 28 Compound 1 was spectroscopically pure and its structural determinations were based upon 1 H NMR, DEPT, COSY, 1 H- 13 C HMQC and long range HMBC and 1D-nOe experiments as well as by MALDI-TOF mass spectrometry (see supporting information). Compound 1 was debenzylated using 20% Pd(OH) 2 /C and ammonium formate under reflux in methanol for 4h, followed by 5′-dimethoxytritylation to give 2 (two step 78%), which was 3′-phosphitylated to give the phosphoramidite 3 using standard conditions. 29 The
31
P NMR spectrum of compound 3 showed that this phosphoramidite was pure (Figure 2) , hence was used for oligo-DNA synthesis directly. 
(B) Synthesis and thermal denaturation studies of BHNA incorporated AONs
The phosphoramidite 3 was incorporated into a 15mer DNA sequence by solid supported DNA synthesis protocol on Applied Biosystems 392 RNA/DNA synthesizer. Standard DNA synthesis cycle (1 µmol scale) and common reagents 29 were used except for incorporating modified nucleotides 3 by using a coupling time of 10 minutes. Cleavage of oligos from the support and deprotection was carried out just by treating the solid support with 33% aqueous ammonia at room temperature for 12 h. The fully-deprotected AONs were then purified by 20% denatured PAGE. The selected 15mer DNA sequence is targeted to the coding region of SV40 large T antigen. 30 Four sequences were synthesized and each sequence has single modification of BHNA but at different sites of the 15mer DNA sequence. The sequences and modification position are shown in Table 1 . The integrity of AONs was corroborated by MALDI-TOF mass measurement (see Table 1 ). The affinity of AONs 2-5 toward their complementary strands, DNA or RNA, were evaluated by UV melting experiments ( Table 1 ). The melting temperatures (T m ) of duplex between native AON 1 and complementary DNA and RNA were 45.5ºC and 44.7ºC, respectively. The T m s of AONs 2-5/DNA duplexes were 5.8-11.5ºC lower than the native counterpart AON 1/ DNA. The terminal modification in the sequence AON 2 showed however relatively less T m decrease (-5.8ºC) compared to the modification introduced in the middle of the sequences, AONs 3-5 (-10 to -11 ºC decrease). This sequence-dependent T m decrease suggests the BHNA probably caused a global conformational change in the AON/DNA duplex.
BHNA also destabilized the AON/RNA duplex, but this effect is much less than in the AON/DNA duplexes, in view of the fact AONs 2-5/RNA heteroduplexes showed only T m decrease of -4.3 to -5.5 ºC. Moreover, the middle-modified sequences AONs 3-5 showed a more moderate reduction of T m (-4.1 to -4.3ºC) compared to the terminal modified sequence AON 2. These observations suggest the BHNA only cause local structural perturbation in the AON/RNA duplexes, which means that it could be still be a good substrate for RNase H digestion.
In order to validate this hypothesis that BHNA only introduced a local conformational heterogeneity in AON/RNA hybrid duplex, AON 5 was used to target RNAs 2-4 ( Table 2) Figure 4A . The cleavage rates were determined by densitometric quantification of gels and subsequently by plotting the uncleaved RNA fraction as a function of time ( Figure 4B ). The reaction rates were obtained by fitting the degradation curves to single-exponential decay functions. 31 The relative cleavage rates for AONs 2-5/RNA duplexes were found to be very similar to that of native counterpart ( Figure 4C ). Cleavage pattern of AONs 1-5/RNA hybrids was also compared to shed light as to how much local structure was disrupted by the BHNA modification ( Figure 4D ). In the native hybrid duplex AON 1/RNA, the whole region from A5 to U11 was accessible for RNase H promoted cleavage with a slight preference at the 3′-phosphate of A8. In the case of AON 2, the modification opposite A3 of the complementary RNA made the region A3-A7 inaccessible for RNase H cleavage while A8 remain the major cleavage site. For AON 3, the modification opposite A6 of RNA result in loss of RNase H promoted cleavage in the region A6-A10. Instead, U11 and A13 appeared as the major cleavage sites. The AON 4/RNA hybrid duplex also show unique cleavage pattern toward RNase H incubation. The region of A8-G12 affected by the modification is not accessible for cleavage and the major cleavage sites were shifted to A6 and A13. As expected, the modification opposite A10 of the complementary RNA, as in the AON 5, result in the absence of any cleavage sites in the region A10-A14, while regaining all the cleavage sites from A5 to A8 present in the native hybrid duplex, and A8 remain the major cleavage site. So cleavage activity of RNase H was suppressed with a region, about 5-6 basepairs long, towards the 3′-end of the RNA in the AON/RNA hybrid, starting from the base opposite the modified T nucleotide in the AON strand. The RNase H promoted cleavage has a preference at the middle site A8 of the RNA strand. If A8 is included within the modification region (a stretch of 5 basepairs), the major cleavage site just shift to the edges of the modification region.
(E) Blood serum stability of BHNA incorporated AONs
The stability of AONs toward various exo-and endonucleases is necessary in order to develop therapeutic oligonucleotides. Here, the stability of BHNA modified oligonucleotides in human blood serum was studied and compared with native counterpart. Since human blood serum is mainly composed of 3′-exonuclease, 32 the oligonucleotide with a single BHNA modification at position 3 from 3′-end (AON 2) was choosen to test the BHNA′s stability in human blood serum. Thus, the AON 1 and AON 2 ( 32 P-labeled at the 5′-end) were incubated with human blood serum (male, type AB) at 21˚C. Aliquots were taken out at specific time points and analyzed by 20% denatured PAGE. The gel pictures after autoradiography are shown in Figure 5 . The native AON 1 is not stable in human blood serum and was completely degraded in 4 h. For modified AON 2, the last nucleotide dC was first removed to give the 14mer as the predominant fragment in 1 h. The 14 mer fragment thus produced was found to be resistant to nucleases up to 24 h. In view of the presence of alkaline phosphatase in blood serum which removed the 5′-end 32 P-label gradually, the BHNA incorporated AON should be even more stable than we observed here (24 h). Thus the work described show that the 3′-phosphodiester linkage of BHNA modified AONs is relatively more resistant to nucleases digestion compared to that of native AONs, and the BHNA integrated oligonucleotides could be have potential therapeutic application in the future. 
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(D) C) show that the modification of BHNA lead to a much more significant conformational perturbation in AON/DNA duplex. The base of BHNA points at the major groove, and stereochemically not favored to form any hydrogen bond with the base of the opposite nucleotide. This perturbation stretches along the phosphate backbone and affect the conformation of neighboring nucleotides. This model offers a plausible explanation why BHNA causes a serious T m (ca -10°C) loss and global conformational change in AON/DNA duplex compared to the native DNA/DNA duplex.
The BHNA integrated AON/RNA duplex elicits RNase H, but no RNA cleavage can however be detected in a five to six nucleotide gap starting from the corresponding 3′-end of the modification site in the AON strand. This is very similar to what we have observed earlier with other North-type conformationally constrained systems such as oxetane 15 azitidine 16, 17 or aza-ENA 12 based AONs/RNA duplexes. This can be attributed to the local conformational change from DNA•RNA type to the RNA•RNA type conformation, which is not a substrate to RNase H. This local conformational change for a stretch of 5-6 nucleotides is however not detectable either by CD spectra or by the molecular model. Both of them show that the modified-AON/RNA adopt a perfect conformation similar to that of the native DNA/RNA duplex. 
Conclusions and Implications
(1) The hyper-constrained nucleoside, methylene-bridged hexose (BHNA) was purified and incorporated into antisnese oligonucleotides (AON). 
Experimental Section
General Procedures. Chromatographic separations were performed on Merck G60 silica gel. Thin layer chromatography (TLC) was performed on Merck pre-coated silica gel 60 F254 glassbacked plates.
1
H NMR spectra were recorded at 500 and 600 MHz respectively, using TMS (0.0 ppm) as internal standards. 13 C NMR spectra were recorded at 125.7 MHz and 150.9 MHz respectively, using the central peak of CDCl3 (76.9 ppm) as an internal standard.
31
P NMR spectra were recorded at 202.5 MHz. Chemical shifts (δ scale) are reported in ppm. The nucleobase of the A, C have been protected using fast deprotecting phenoxyacetyl (PAC) and acetyl (AC) groups, respectively. MALDI-TOF mass spectra were recorded in positive ion mode for oligonucleotides and other compounds. All compounds were spectroscopically pure and their structural determinations were based upon 1 H NMR, 13 . To a solution of compound 1 (53 mg, 0.11 mmol) in dry methanol (3mL) was added 20% Pd(OH) 2 /C (168 mg) and ammonium formate (423 mg, 6.7 mmol) and reflux for 1.5h. The suspension was filtered over celite bar and organic phase was evaporated. The residue was co-evaporated twice with dry pyridine and dissolved in the same solvent. 4,4′-Dimethoxytrityl chloride (42 mg, 0.12 mmol) was added and stirred overnight at room temperature. Then the solvent was removed and residue was diluted with DCM, washed with saturated NaHCO 3 solution, dried over MgSO 4 and subjected to chromatography on silica gel (methanol in dichloromethane containing 1% pyridine, 0.5-2%, v/v) to give 2 (52 mg, 78% Absorbance was monitored at 260 nm in the temperature range from 15 °C to 70 °C using an UV spectrophotometer equipped with a Peltier temperature programmer with the heating rate of 1 °C per minute. Prior to measurements, the samples (1 µM of AON and 1µM complementary DNA or RNA mixture) were preannealed by heating to 80 °C for 5 min followed by slow cooling to 20°C and 30 min equilibration at this temperature. The value of T m is the average of two or three (if error of the first two measurement is more than 0.2 °C, the third measurement was carried out) independent measurements.
CD experiments. CD spectra were recorded from 300 to 200 nm in 0.2 cm path length cuvettes. Spectra were obtained with a AON/RNA or AON/DNA duplex concentration of 10 µM in 60 mM Tris-HCl (pH 7.5), 60 mM KCl, 0.8 mM MgCl 2. All the spectra were measured at 20 °C and each spectrum is an average of 5 experiments from which CD value of the buffer was subtracted.
32
P Labeling of oligonucleotides. The oligoribonucleotides and oligodeoxyribonucleotides were 5′-end labeled with 32 P using T4 polynucleotide kinase, [γ-32 P]ATP, and the standard protocol.
Labeled AONs and the target RNA were purified by QIAquick Nucleotide Removal Kit, and specific activities were measured using a Beckman LS 3801 counter.
RNase H digestion assay. Target 0.1 µM RNA (specific activity 80 000 cpm) and a 20-fold excess of AON were incubated in a buffer containing 20 mM Tris-HCl (pH 7.5), 20 mM KCl, 10 mM MgCl 2 , 0.1 mM EDTA, and 0.1 mM DTT at 21 °C in the presence of 0.08 U E. coli RNase H. Prior to the addition of the enzyme, reaction components were preannealed in the reaction buffer by heating at 80 °C for 5 min followed by slow cooling to 21°C and 30 min equilibration at this temperature. Total reaction volume was 30 µL. Aliquots of 3 µL were removed after 3, 7, 15, 25, 40, and 60 min, and the reactions were terminated by mixing with stop solution (4 µL) containing 0.05 M EDTA, 0.05% (w/v) bromophenol blue, and 0.05% (w/v) xylene cyanole in 80% formamide. The samples were subjected to 20% 7 M urea PAGE and visualized by autoradiography.
Stability studies in human serum. AONs at 2 µM concentration (5′-end 32 P labeled with specific activity 80 000 cpm) were incubated in 30µl of human blood serum (male AB) at 21 °C (total reaction volume was 36 µL). Aliquots (3 µL) were taken at 0, 30 min, 1, 2, 6, 8, 10, 12, 24, 36, 48 h, and quenched with 4 µL of solution containing 0.05 M EDTA, 0.05% (w/v) bromophenol blue, and 0.05% (w/v) xylene cyanole in 80% formamide, resolved in 20% polyacrylamide denaturing (7 M urea) gel electrophoresis and visualized by autoradiography.
